Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child-Pugh A Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06487559
What this trial is testing

Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
AbbVie 3
Testing effectiveness (Phase 2)Looking for participantsNCT07219459
What this trial is testing

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Who this might be right for
Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH 104
Large-scale testing (Phase 3)Study completedNCT01075555
What this trial is testing

Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 323
Testing effectiveness (Phase 2)UnknownNCT05616390
What this trial is testing

Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)UnknownNCT00921531
What this trial is testing

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 200
Large-scale testing (Phase 3)UnknownNCT04797884
What this trial is testing

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
THERABIONIC INC. 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495579
What this trial is testing

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Asan Medical Center 146
Early research (Phase 1)Study completedNCT02507765
What this trial is testing

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Child-Pugh Class AChild-Pugh Class BStage IIIA Hepatocellular Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05883644
What this trial is testing

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
AstraZeneca 111
Testing effectiveness (Phase 2)Study completedNCT04829383
What this trial is testing

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Howard S Hochster 6
Early research (Phase 1)Ended earlyNCT01219543
What this trial is testing

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Who this might be right for
Solid TumourAdvanced Solid MalignanciesChild-Pugh A to B7 Advanced Hepatocellular Carcinoma+3 more
AstraZeneca 47
Testing effectiveness (Phase 2)Study completedNCT04522908
What this trial is testing

Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Who this might be right for
Hepatocellular Carcinoma (HCC)Second Line Treatment
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Not applicableStudy completedNCT03534843
What this trial is testing

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Who this might be right for
Rupture, SpontaneousRupture LiverHepatocellular Carcinoma+1 more
Huazhong University of Science and Technology 230
Testing effectiveness (Phase 2)Study completedNCT01988493
What this trial is testing

Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 117
Large-scale testing (Phase 3)Ended earlyNCT02762266
What this trial is testing

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Who this might be right for
Child-Pugh Class AChild-Pugh Class BRecurrent Hepatocellular Carcinoma
Stanford University 13
Large-scale testing (Phase 3)Study completedNCT01903694
What this trial is testing

Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

Who this might be right for
Child-Pugh A Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 474